Ardent Health (ARDT) director receives 14,231-share restricted stock grant

Rhea-AI Filing Summary

Campion Suzanne reported acquisition or exercise transactions in this Form 4 filing.

Ardent Health, Inc. director Suzanne Campion reported receiving a grant of 14,231 shares of common stock in the form of restricted stock units. These units vest in full on the first anniversary of April 1, 2026, if she continues serving with the company through that date. After this award, she directly holds 58,215 shares of common stock, reflecting a routine equity-based compensation grant rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Campion Suzanne

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,231	$0.00	--

Holdings After Transaction: Common Stock — 58,215 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 14,231 shares Grant price: $0.00 per share Post-grant holdings: 58,215 shares

3 metrics

RSU grant size 14,231 shares Restricted stock units granted to director on April 1, 2026

Grant price $0.00 per share Equity compensation grant, not an open-market purchase

Post-grant holdings 58,215 shares Total Ardent Health common stock held directly after transaction

Key Terms

restricted stock units, vest in full, continued service, Grant, award, or other acquisition

4 terms

restricted stock units financial

"Represents restricted stock units that vest in full on the first anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest in full financial

"that vest in full on the first anniversary of April 1, 2026"

continued service financial

"subject to the Reporting Person's continued service with the Issuer"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Campion Suzanne

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		14,231(1)	A	$0	58,215	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Ardent Health (ARDT) director Suzanne Campion report?

Suzanne Campion reported receiving 14,231 shares of Ardent Health common stock as a restricted stock unit grant. The award is a form of equity compensation, not an open-market purchase, and increases her direct beneficial holdings reported in this filing.

How many Ardent Health (ARDT) shares does Suzanne Campion hold after this grant?

After the reported grant, Suzanne Campion holds 58,215 shares of Ardent Health common stock directly. This total includes the 14,231 restricted stock units awarded in the transaction disclosed in the Form 4 insider filing.

When do Suzanne Campion’s new restricted stock units in Ardent Health (ARDT) vest?

The restricted stock units vest in full on the first anniversary of April 1, 2026, according to the footnote. Vesting is contingent on Suzanne Campion’s continued service with Ardent Health through that vesting date.

Did Suzanne Campion buy Ardent Health (ARDT) shares on the open market?

No, the filing shows a code “A” grant, meaning a grant or award acquisition at $0.00 per share. This reflects equity compensation in restricted stock units, not an open-market purchase or sale of existing Ardent Health shares.

What does the $0.00 price per share mean in the Ardent Health (ARDT) Form 4?

The $0.00 price per share indicates the shares were granted as compensation, not bought for cash. Suzanne Campion received 14,231 restricted stock units at no purchase cost under Ardent Health’s equity compensation arrangements.